align-toparrow-leftarrow-rightbackbellblockcalendarcamerachatcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-crosscrosseditfacebookglobegoogleimagesinstagramlocation-pinmagnifying-glassmailmoremuplabelShape 3 + Rectangle 1outlookpersonplusImported LayersImported LayersImported Layersshieldstartwitteryahoo

The Safety and Effectiveness of Investigational Drugs In Treating Celiac Disease

CSA Long Island Celiac Disease Support Group is pleased to announce on March 20th, 2013 at 7:30PM Dr. David Eskreis will present “The Safety and Effectiveness of Investigational Drugs In Treating Celiac Disease”

Dr. Martin Spatz Conference Center
Room A
Winthrop-University Hospital
259 First Street
Mineola NY 11501
Conference Center is located on the Lower Level in the Main Hospital Building

Dr. David Eskreis is a board certified gastroenterologist with twenty-five years of experience managing patients with digestive and liver problems. He cares for patients with the full spectrum of digestive conditions including, but not limited to, abdominal pain, bleeding, IBS (irritable bowel syndrome), reflux, hemorrhoids, and routine cancer screening. His practice has a specialized interest in managing patients with complex problems related to inflammatory bowel disease (ulcerative colitis and Crohn's disease) and Celiac Disease. Dr. Eskreis participates in numerous clinical research trials with patients who suffer with severe symptoms of ulcerative colitis, Crohn's disease, or Celiac disease. He also participates in the training of fellows in gastroenterology at North Shore Hospital where he is an active staff physician.

REFRESHMENTS WILL BE SERVED

Please contact Barbara Callanan at[masked] if you have any questions.

Click here find additional information on the clinical research that Dr. Eskreis is conducting in conjunction with Alba Therapeutics.

Join or login to comment.

7 went

Our Sponsors

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy